Dries P, Verstraete B, Allaeys M, Van Hoef S, Eker H, Berrevoet F
Department for General and HPB Surgery and Liver Transplantation, Ghent University Hospital, Ghent, Belgium.
Hernia. 2024 Jun;28(3):895-904. doi: 10.1007/s10029-024-03039-3. Epub 2024 Apr 23.
The precise indications for employing the anterior component separation technique (ACST) and the Transversus Abdominis Release (TAR) in abdominal wall reconstruction (AWR) remain uncertain, despite the undeniable value of both techniques. The aim of this study was to analyze the anterior fascial closure rate, postoperative wound morbidity, and hernia recurrence rate for both procedures according to the algorithm used for complex AWR.
A retrospective analysis of prospectively collected data was carried out. Patients undergoing AWR for midline incisional hernias using either open or endoscopic ACST (E-ACST) or TAR between March 2013 and August 2022 were included. Patients with lateral hernia components were excluded. The surgical technique was depending on the pre- and intraoperative findings regarding hernia width and on the estimated traction to achieve anterior fascial closure (see algorithm). Initially, intermediate hernia defects ranging from approximately 10-14 cm in width were repaired using E-ACST. However, as the study advanced, TAR became the preferred method for addressing these types of defects. Open ACST was consistently employed for defects wider than 14-15 cm throughout the entire study duration. Outcomes of interest were anterior fascial closure, surgical site occurrences, and hernia recurrence rate. Follow-up was performed at 1 month, 1 year, and 2 years.
A total of 119 patients underwent AWR with CST: 63 patients (52.9%) were included in the ACST group and 56 patients (47.1%) in the TAR group. No significant differences were observed in patient and hernia characteristics. The use of botulinum toxin A (BTA) injection and preoperative progressive pneumoperitoneum (PPP) was more frequently used in the ACST group (BTA 19.0%, PPP 15.9% versus BTA 5.4%, PPP 1.8% for TAR patients). Anterior fascial closure was achieved in 95.2% of the ACST group and 98.2% of the TAR group (p = 0.369). The TAR group demonstrated a significantly lower SSO rate at one month (44.3% versus 14.3%, p < 0.001) and required fewer procedural interventions (SSO-PI) (31.1% versus 8.9%, p = 0.003). The recurrence rate at one year was low and there was no statistically significant difference between the two groups (ACST 1.8% vs TAR 4.5%, p = 0.422).
Following a proposed algorithm, the anterior fascial closure rate was high and similar for both techniques. As postoperative wound morbidity is significantly increased after ACST, our findings support recommending TAR for defects up to 14 cm in width, while favoring open ACST for larger defects.
尽管前入路成分分离技术(ACST)和腹横肌松解术(TAR)在腹壁重建(AWR)中都具有不可否认的价值,但其具体应用指征仍不明确。本研究的目的是根据复杂腹壁重建所采用的算法,分析这两种手术方法的前筋膜关闭率、术后伤口并发症发生率和疝复发率。
对前瞻性收集的数据进行回顾性分析。纳入2013年3月至2022年8月期间采用开放或内镜下ACST(E-ACST)或TAR进行中线切口疝腹壁重建的患者。排除伴有外侧疝成分的患者。手术技术取决于术前和术中关于疝宽度的发现以及为实现前筋膜关闭所需的估计牵拉力(见算法)。最初,宽度约为10-14cm的中度疝缺损采用E-ACST修复。然而,随着研究的进展,TAR成为处理这类缺损的首选方法。在整个研究期间,开放ACST一直用于宽度超过14-15cm的缺损。关注的结果指标为前筋膜关闭情况、手术部位并发症及疝复发率。随访在术后1个月、1年和2年进行。
共有119例患者接受了CST腹壁重建手术:ACST组63例(52.9%),TAR组56例(47.1%)。患者和疝的特征方面未观察到显著差异。ACST组更频繁地使用A型肉毒杆菌毒素(BTA)注射和术前渐进性气腹(PPP)(ACST组BTA为19.0%,PPP为15.9%;TAR组患者BTA为5.4%,PPP为1.8%)。ACST组95.2%的患者实现了前筋膜关闭,TAR组为98.2%(p = 0.369)。TAR组在术后1个月时手术部位并发症发生率显著更低(44.3%对14.3%,p < 0.001),且所需的手术干预更少(手术部位并发症相关手术干预,SSO-PI)(31.1%对8.9%,p = 0.003)。1年时的复发率较低,两组之间无统计学显著差异(ACST组为1.8%,TAR组为4.5%,p = 0.422)。
遵循所提出的算法,两种技术的前筋膜关闭率都很高且相似。由于ACST术后伤口并发症显著增加,我们的研究结果支持对于宽度达14cm的缺损推荐使用TAR,而对于更大的缺损则倾向于采用开放ACST。